Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Novozymes A/S
F:NZM2
Novozymes A/S
F:NZM2
Price:
56.9
EUR
0.07%
Market Cap:
€23.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Novozymes A/S
F:NZM2
|
DK |
|
W
|
Waste Management Inc
XMUN:UWS
|
US |
|
A
|
Altria Group Inc
XMUN:PHM7
|
US |
|
E
|
Exor NV
DUS:EYX
|
NL |
|
Y
|
Yokohama Rubber Co Ltd
DUS:YRB
|
JP |
|
Avi Ltd
F:IZ6
|
ZA |
|
B
|
BP PLC
F:BPE5
|
UK |
|
Brown-Forman Corp
NYSE:BF.A
|
US |
|
Aviva PLC
OTC:AIVAF
|
UK |
|
A
|
Advanced Micro Devices Inc
XHAM:AMD
|
US |
|
A
|
AXA SA
F:AXA
|
FR |
|
P
|
Pro Medicus Ltd
F:PMC
|
AU |
|
S
|
Starwood Property Trust Inc
LSE:0L9F
|
US |
|
A
|
Advantest Corp
F:VAN
|
JP |
|
B
|
Banco Santander SA
XHAM:BSD2
|
ES |
|
E
|
Ems Chemie Holding AG
XMUN:EMC1
|
CH |
|
R
|
Regeneron Pharmaceuticals Inc
F:RGO
|
US |
|
Subsea 7 SA
F:SOCA
|
UK |
|
Vimian Group AB
F:0V0
|
SE |
|
P
|
Proto Labs Inc
F:PRZ
|
US |
|
L
|
Lam Research Corp
F:LAR
|
US |
|
F
|
FedEx Corp
BMV:FDX
|
US |
|
T
|
TotalEnergies SE
NYSE:TTE
|
FR |
|
Epiroc AB
F:3AD1
|
SE |
Wall St Price Targets
NZM2 Price Forecast
Based on 19 analysts
Based on 19 analysts
+19% Upside
from
€56.9
today
Novozymes A/S (NZM2)’s 12-month stock price forecast through September 2027 has a consensus target of €67.86, implying 19% upside. The forecast is based on price targets from 19 Wall Street analysts.
NZM2 Analyst Rating
No ratings yet
No ratings yet
Novozymes A/S Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NZM2's stock price target?
Price Target
67.86
EUR
67.86
EUR
According to Wall Street analysts, the average 1-year price target for NZM2 is 67.86 EUR with a low forecast of 55.64 EUR and a high forecast of 75.45 EUR.
What is the Revenue forecast for Novozymes A/S?
Projected CAGR
-55%
-55%
Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is -55%.
What is the Net Income forecast for Novozymes A/S?
Projected CAGR
-56%
-56%
Over the last 7 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is -56%.